­
­
­
­

Inventi Impact: Oncology

Articles

  • Inventi:hoc/21611/17
    ZFP91: A Noncanonical NF- B Signaling Pathway Regulator with Oncogenic Properties Is\nOverexpressed in Prostate Cancer
    01-Jan-1970 Research 2017 : January - March
    Lukasz Paschke, Karol Jopek, Marta Szyszka, Marianna Tyczewska, Agnieszka Ziolkowska, Marcin Rucinski, Ludwik K Malendowicz

    Novel molecular targets are being searched to aid in prostate cancer diagnosis and therapy. Recently, ZFP91 zinc finger protein has\nbeen found to be upregulated in prostate cancer cell lines. It is a potentially important oncogenic protein; however only limited\ndata regarding its biological function and expression patterns are available. To date, ZFP91 has been shown to be a key factor in\nactivation of noncanonical NF-

    How to Cite this Article
    CC Compliant Citation: Lukasz Paschke, Karol Jopek, Marta Szyszka, et al., â??ZFP91: A Noncanonical NF-B Signaling Pathway Regulator\nwith Oncogenic Properties Is Overexpressed in Prostate Cancer,â? BioMed Research International, vol. 2016, Article ID 6963582, 8 pages,\n2016. doi:10.1155/2016/6963582, https://creativecommons.org/licenses/by/4.0/.
    Download Full Text